Elite Pharmaceuticals Inc (ELTP)

[Hike]

IPCI is very interesting. On one hand they have yet to go beyond Phase I with Rexista, yet the FDA has apparently given them the path to bypass Phase III. IPCI's low market cap of $51,000,000 makes it an interesting play in and of itself. Yet stock was $3.38 when FDA announced fast track OK...and today is $2.15. Elite has been through multiple Phase 1, 2, 3 (soon!), HAL, BE, etc studies...